Suppr超能文献

慢性疼痛患者接受非阿片类药物和阿片类药物治疗的不良反应。

Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain.

机构信息

Oncology Unit, Ospedali Riuniti di Bergamo, Bergamo, Italy.

出版信息

Clin Drug Investig. 2012 Feb 22;32 Suppl 1:53-63. doi: 10.2165/11630080-000000000-00000.

Abstract

Chronic pain is a debilitating condition that is associated with many common diseases; this places a major burden on the healthcare system. There are currently numerous analgesic agents available for the treatment of chronic pain. In general, the oral non-opioid analgesic, paracetamol, is recommended for the initial treatment of mild to moderate pain. Therapeutic doses of paracetamol do not appear to result in hepatotoxicity, although overdose may lead to acute liver failure. Current data suggest that paracetamol has acceptable gastrointestinal tolerability. Another class of non-opioid analgesic with confirmed efficacy for the treatment of chronic mild to moderate pain are non-steroidal anti-inflammatory drugs (NSAIDs), although this efficacy is offset by the potential of adverse gastrointestinal events. In particular, non-selective NSAIDs, also known as cyclooxygenase (COX) inhibitors, carry an increased risk of serious upper gastrointestinal complications, including ulcers, perforation and bleeding. The introduction of COX-2 inhibitors provided a NSAID-based option with improved gastrointestinal safety, but increased risk of cardiovascular effects. Opioids are powerful analgesic agents used to treat moderate to severe chronic pain. However, treatment with opioids is associated with a number of common adverse effects, including constipation, nausea or vomiting, pruritus, somnolence or cognitive impairment, dry mouth, tolerance or dependence and urinary retention. Although there are multiple strategies in place to manage adverse events that arise from both non-opioid and opioid analgesic therapy, a better understanding of the mechanisms involved in the development of specific drug-related adverse effects is required along with proper prescribing practices and adequate physician/patient education. Balanced against the adverse effects of pain management medications, there is a need to be mindful of the widespread, often serious, adverse consequences of poorly managed pain itself.

摘要

慢性疼痛是一种使人虚弱的病症,与许多常见疾病有关;这给医疗保健系统带来了巨大的负担。目前有许多镇痛药可用于治疗慢性疼痛。一般来说,建议使用口服非阿片类镇痛药对乙酰氨基酚来治疗轻度至中度疼痛。治疗剂量的对乙酰氨基酚似乎不会导致肝毒性,尽管过量可能导致急性肝衰竭。目前的数据表明,对乙酰氨基酚具有可接受的胃肠道耐受性。另一类已被证实对治疗慢性轻度至中度疼痛有效的非阿片类镇痛药是非甾体抗炎药(NSAIDs),尽管其疗效因潜在的胃肠道不良事件而受到影响。特别是,非选择性 NSAIDs,也称为环氧化酶(COX)抑制剂,存在严重上胃肠道并发症的风险增加,包括溃疡、穿孔和出血。COX-2 抑制剂的引入提供了一种基于 NSAID 的选择,具有改善的胃肠道安全性,但心血管效应的风险增加。阿片类药物是用于治疗中度至重度慢性疼痛的强效镇痛药。然而,阿片类药物治疗与许多常见的不良反应相关,包括便秘、恶心或呕吐、瘙痒、嗜睡或认知障碍、口干、耐受或依赖以及尿潴留。尽管有多种策略可用于管理非阿片类和阿片类镇痛药治疗引起的不良反应,但需要更好地了解特定药物相关不良反应发展的机制,同时还需要适当的处方实践和充分的医生/患者教育。在权衡疼痛管理药物的不良反应的同时,还需要注意未得到良好管理的疼痛本身所带来的广泛的、往往是严重的不良后果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验